# Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study

> **NCT03898388** · NA · TERMINATED · sponsor: **Regenexx, LLC** · enrollment: 47 (actual)

## Conditions studied

- Knee Osteoarthritis

## Interventions

- **PROCEDURE:** Bone Marrow Concentrate treatment

## Key facts

- **NCT ID:** NCT03898388
- **Lead sponsor:** Regenexx, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-03-21
- **Primary completion:** 2020-10-30
- **Final completion:** 2022-03-30
- **Target enrollment:** 47 (ACTUAL)
- **Why stopped:** sponsor discontinued study-impacted by COVID
- **Last updated:** 2023-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03898388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03898388, "Correlating the OA Knee Microenvironment to Outcomes After Regenexx-SD Treatment: A Multi-Site Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03898388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*